Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - TOTAL EQUITY
Total Equity ALNY - Alnylam Pharmaceuticals, Inc.
67.1 M
LAST VALUE
55.69%
2 YEAR CAGR
-45.83%
5 YEAR CAGR
-23.17%
10 YEAR CAGR